Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxysterol-binding protein-related protein 4 is a cytosolic lipid transfer protein with a conserved oxysterol-binding domain and pleckstrin homology motif, controlling the movement of sterols (cholesterol, 25-hydroxycholesterol) and phospholipids (phosphatidylinositol-4-phosphate) between cell membranes[1][3][7][8]. ORP4 is expressed in human brain, heart, muscle, and kidney, and exists as several isoforms with distinct cellular localization and functions[1][3][8]. ORP4 is uniquely required for the proliferation and survival of rapidly dividing and transformed cells, supporting intracellular calcium homeostasis and activating gene clusters that sustain cell growth[4][5]. It interacts with vimentin intermediate filaments, regulating cytoskeletal organization and cholesterol transport[1][3][4][8]. Small-molecule inhibition of ORP4 impairs cancer cell viability, making it a potential therapeutic target in oncology and antiviral research[13][15].
Inhibition of ORP4 impairs cancer cell proliferation and survival by modulating lipid homeostasis, calcium signaling, and apoptosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxysterol-binding protein-related protein 4 (ORP4).